secwatch.observer — SEC 8-K summary
======================================

Issuer:     GUIDED THERAPEUTICS INC (GTHP)
CIK:        0000924515
Form:       8-K
Filed at:   2021-07-27T23:59:59+00:00
Accession:  0001121781-21-000023
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Guided Therapeutics shareholders approve reverse split and charter changes at annual meeting
--------------------------------------------------------------------------------

- All seven proposals approved at July 22, 2021 annual meeting.
- Reverse split up to 1-for-20 authorized; board may decide by Dec 31, 2021; 15.58M for.
- Authorized common reduced from 3B to 500M shares; 15.69M for.
- Series F preferred authorized increased to 4,000 from 1,500; 15.51M for.
- Advisory compensation vote and one-year frequency approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/924515/000112178121000023/0001121781-21-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/924515/000112178121000023/gthp8k72721.htm
  HTML page:      https://secwatch.observer/filing/0001121781-21-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer